PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | C0239946|liver fibrosis |
| Sentences | 81 |
| PubMedID- 23113588 | In this study, we investigated the role of c5a and its receptor in liver fibrosis in patients with hepatitis b virus infection. |
| PubMedID- 25232240 | Noninvasive assessment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 22462232 | Objective: to investigate the clinical efficacy and safety of the ganning formula for the treatment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 25548740 | Conclusions: serum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 24074710 | Supplemental fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis b following unsatisfactory outcome of nucleos(t)ide analogue monotherapy. |
| PubMedID- 26448760 | Similarly, phase ii trials of a human monoclonal antibody for ctgf (fg 3019) for patients with liver fibrosis (due to chronic hepatitis b infection) and pulmonary fibrosis are promising. |
| PubMedID- 23080492 | Influence of b cells in liver fibrosis associated with hepatitis b virus harboring basal core promoter mutations. |
| PubMedID- 24612251 | Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis b--a prospective cohort study with paired transient elastography examinations. |
| PubMedID- 26201770 | Non-invasive assessment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 23874760 | Although the search for new biomarkers is quite active, information on the stages of liver fibrosis in patients with chronic hepatitis b is available from routine hematologic tests, such as the complete blood count. |
| PubMedID- 26427080 | Efficacy and safety of fuzhenghuayu capsule for treating liver fibrosis in patients with chronic hepatitis b: a meta-analysis. |
| PubMedID- 26082614 | Lmv, a pharmacon of low cost, rare side effects, and high effect in inhibiting hbv replication and promoting hbeag seroconversion, has been proven to be able to achieve regression of fibrosis/cirrhosis and, improve the histology and disease progression in advanced liver fibrosis/cirrhosis with chronic hepatitis b patients,26 so it is still a fairly good rescue pharmacon for adefovir dipivoxil resistance in the economically less developed regions, since rescue therapy can be carried out by using etv or tdf, even if multidrug resistance to lmv and adv happens.27,28 as another pharmacon of high effect in inhibiting hbv replication and promoting hbeag seroconversion with less drug resistance but for a higher cost and a side effect of creatine kinase elevation,29 ldt is an alternative rescue pharmacon for adefovir dipivoxil resistance in economically less developed regions. |
| PubMedID- 25308941 | The aims of this study were to compare the performance of acoustic radiation force impulse (arfi) elastography and transient elastography (te) in the assessment of liver fibrosis in patients with chronic hepatitis b and to evaluate the impact of elevated alanine transaminase levels on liver stiffness assessment using arfi elastography. |
| PubMedID- 22772739 | We aimed to determine the optimal time for restoring the reliability of lsm for assessing liver fibrosis in patients with chronic hepatitis b experiencing acute exacerbation. |
| PubMedID- 20207872 | Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis b virus (hbv)-infected patients in burkina faso. |
| PubMedID- 23898389 | We aimed to study the relationship between metabolic syndrome and the risk of liver fibrosis in patients with chronic hepatitis b (chb) and chronic hepatitis c (chc). |
| PubMedID- 26201342 | Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 23107442 | Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 23510962 | Apri, the fib-4 score, and forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 25966326 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 21095512 | liver fibrosis in hepatitis b: a dynamic process. |
| PubMedID- 25788201 | Adipocytokines and liver fibrosis stages in patients with chronic hepatitis b virus infection. |
| PubMedID- 23405210 | Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary not only to predict the long-term clinical course, but also to determine whether and when to begin antiviral therapy. |
| PubMedID- 23227248 | Specifically, ir is the key determinant of nonalcoholic fatty liver disease (nafld) and its severity , due to both viral and host factors , . |
| PubMedID- 26260921 | liver fibrosis develops in patients with chronic hepatitis b because of repeated necroinflammation, followed by hepatocyte regeneration and the accumulation of extracellular matrix (ecm) proteins, such as collagen56. |
| PubMedID- 23860694 | A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis b infection. |
| PubMedID- 21110425 | Objective: to evaluate the relationship of the expression of bone morphogenefic protein-7 (bmp-7) in the liver and the liver fibrosis and inflammation in patients with chronic hepatitis b virus (hbv) infection, to explore the role of bmp-7 in the fibrogenesis of chronic hepatitis b. |
| PubMedID- 26088852 | Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 24995107 | In this study, we aimed to investigate the association between thrombopoietin (tpo) levels and the stage of liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 22176964 | Objective: to evaluate the value of transient elastography (te) for predicting severity of liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 24631902 | The aim of this study was to describe the diagnostic performance of fibrotest(r), fibrometer(r), and hepascore(r) for liver fibrosis in hepatitis b compared to hepatitis c. |
| PubMedID- 24290780 | Aim: to evaluate the utility of the elastic ratio calculated using real-time tissue elastography for assessing liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 19951379 | Our present study aimed to evaluate the use of serum glycan markers for the diagnosis of liver fibrosis in patients with chronic hepatitis b infection. |
| PubMedID- 20505530 | An early marker predictive of liver fibrosis in hepatitis b e antigen (hbeag)-negative chb patients can alert clinicians to plan for treatment before disease progression. |
| PubMedID- 23049764 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis b: a meta-analysis. |
| PubMedID- 26391629 | A novel non-invasive index using afp and aptt is associated with liver fibrosis in patients with chronic hepatitis b infection: a retrospective cohort study. |
| PubMedID- 25651500 | Acoustic radiation force impulse elastography, fibroscan(r), forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis b, and the impact of inflammatory activity and steatosis on these diagnostic methods. |
| PubMedID- 20620694 | We investigated the use of contrast-enhanced ultrasonography (ceus) with quantitative measurements to assess the stages of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 25911714 | Differences in liver fibrosis between patients with chronic hepatitis b and c: evaluation by acoustic radiation force impulse measurements at 2 locations. |
| PubMedID- 26402972 | Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis b with undetectable hbv dna and persistently normal alanine aminotransferase. |
| PubMedID- 24735137 | Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis b. |
| PubMedID- 26486937 | Objectives: to prospectively investigate the usefulness of acoustic structure quantification (asq) for noninvasive assessment of liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 24829585 | Although anti-hbsp test did not show any significant association with parameters of viral replication and liver inflammation, it delivered partial indication on liver fibrosis associated with chronic hepatitis b. |
| PubMedID- 26573189 | Objective: to determine the diagnostic value of fibrotest (ft) for liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 25637160 | Effect of dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis b: a meta-analysis. |
| PubMedID- 23358121 | Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis b virus infection. |
| PubMedID- 25167956 | Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis b. |
| PubMedID- 24721240 | Objective: to prospectively evaluate the efficacy of a traditional chinese medicine (tcm)-based therapy for treating liver fibrosis in patients with chronic hepatitis b (chb), and to investigate the patients' perception of the treatment's effects on quality of life (qol). |
| PubMedID- 23791352 | Tdi and tsi with quantitative measurements using tissue doppler analysis software (tdiq, ge medical systems, horten, norway) provided reliable information for evaluating non-invasive liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 24371101 | Objectives: to evaluate quantitative measurement of spleen stiffness for indirect assessment of liver fibrosis in patients with chronic hepatitis b and to correlate spleen stiffness with liver stiffness using pathologic examination as a reference standard. |
Page: 1 2